Stock 000950 C.Q. PHARMACEUTICAL HOLDING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials C.Q. Pharmaceutical Holding Co., Ltd.

Equities

000950

CNE0000010K0

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
5.34 CNY -0.56% Intraday chart for C.Q. Pharmaceutical Holding Co., Ltd. -2.02% +7.44%
Apr. 26 C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 12 C.Q. Pharma's Unit Gets Nod to Market Pregabalin Capsules MT

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 8,856 8,589 9,229 -
Enterprise Value (EV) 1 8,856 8,589 9,229 9,229
P/E ratio 9.24 x 13.1 x 8.34 x 7.17 x
Yield - - 1.5% 1.69%
Capitalization / Revenue - 0.11 x 0.1 x 0.09 x
EV / Revenue - 0.11 x 0.1 x 0.09 x
EV / EBITDA - 6.85 x 2.73 x 2.42 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - 0.72 x 0.65 x
Nbr of stocks (in thousands) 1,743,367 1,728,185 1,728,185 -
Reference price 2 5.080 4.970 5.340 5.340
Announcement Date 4/26/23 4/26/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 80,119 90,583 101,654
EBITDA 1 - 1,254 3,377 3,807
EBIT 1 - 1,007 1,557 1,795
Operating Margin - 1.26% 1.72% 1.77%
Earnings before Tax (EBT) 1 - 1,009 1,894 2,224
Net income 1 952.3 655 1,105 1,291
Net margin - 0.82% 1.22% 1.27%
EPS 2 0.5500 0.3800 0.6400 0.7450
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - 0.0800 0.0900
Announcement Date 4/26/23 4/26/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - - 7.9% 8.2%
ROA (Net income/ Total Assets) - - 1.6% 1.7%
Assets 1 - - 69,062 75,941
Book Value Per Share 2 - - 7.410 8.180
Cash Flow per Share 2 - - 0.8200 0.5000
Capex - - - -
Capex / Sales - - - -
Announcement Date 4/26/23 4/26/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for C.Q. Pharmaceutical Holding Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.34
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
C.Q. PHARMACEUTICAL HOLDING CO., LTD. Stock C.Q. Pharmaceutical Holding Co., Ltd.
+7.44% 1.27B
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 000950 Stock
  4. Financials C.Q. Pharmaceutical Holding Co., Ltd.